NVDA vs SCSC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.
SCSC presents a classic value-trap profile, characterized by a stable Piotroski F-Score of 4/9 and a significant discount to its Graham Number ($55.39) and Intrinsic Value ($57.19). While valuation metrics are exceptionally attractive (P/B < 1.0, PEG 0.58), the company suffers from razor-thin profit margins and stagnant revenue growth. The bullish valuation case is heavily offset by bearish insider activity from the CEO and CFO and a recent decline in quarterly EPS growth. Consequently, the stock is fundamentally undervalued but lacks a clear immediate catalyst for growth.
Compare Another Pair
Related Comparisons
NVDA vs SCSC: Head-to-Head Comparison
This page compares NVIDIA Corporation (NVDA) and ScanSource, Inc. (SCSC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.